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An integrated approach that combines reverse-phase high-performance liquid
chromatography (RP-HPLC), electrospray ionization mass spectrometry, untargeted
ultra-performance liquid chromatography coupled to tandem mass spectrometry
(UPLC-MSE) and molecular networking (using the Global Natural Products Social
molecular network platform) was used to elucidate the metabolic profiles and chemical
structures of the secondary metabolites produced by pigmented (P1) and non-pigmented
(NP1) Serratia marcescens (S. marcescens) strains. Tandem mass spectrometry-based
molecular networking guided the structural elucidation of 18 compounds for the P1 strain
(including 6 serratamolides, 10 glucosamine derivatives, prodigiosin and serratiochelin A)
and 15 compounds for the NP1 strain (including 8 serratamolides, 6 glucosamine
derivatives and serratiochelin A) using the MSE fragmentation profiles. The
serratamolide homologues were comprised of a peptide moiety of two L-serine
residues (cyclic or open-ring) linked to two fatty acid chains (lengths of C10, C12, or
C12:1). Moreover, the putative structure of a novel open-ring serratamolide homologue was
described. The glucosamine derivative homologues (i.e., N-butylglucosamine ester
derivatives) consisted of four residues, including glucose/hexose, valine, a fatty acid
chain (lengths of C13 – C17 and varying from saturated to unsaturated) and butyric
acid. The putative structures of seven novel glucosamine derivative homologues and
one glucosamine derivative congener (containing an oxo-hexanoic acid residue instead of
a butyric acid residue) were described. Moreover, seven fractions collected during RP-
HPLC, with major molecular ions corresponding to prodigiosin, serratamolides (A, B, and
C), and glucosamine derivatives (A, C, and E), displayed antimicrobial activity against a
clinical Enterococcus faecalis S1 strain using the disc diffusion assay. The minimum
inhibitory and bactericidal concentration assays however, revealed that prodigiosin
exhibited the greatest antimicrobial potency, followed by glucosamine derivative A and
then the serratamolides (A, B, and C). These results provide crucial insight into the
secondary metabolic profiles of pigmented and non-pigmented S. marcescens strains
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and confirms that S. marcescens strains are a promising natural source of novel
antimicrobial metabolites.
Keywords: pigmented and non-pigmented Serratia marcescens, molecular networking, prodigiosin, serratamolide,
glucosamine derivative, UPLC-MSE
INTRODUCTION
Serratia species are facultatively anaerobic, Gram-negative rods
that are classified into the Enterobacteriaceae family (Grimont
and Grimont, 2015). The type strain of this genus, Serratia
marcescens (S. marcescens), is widely known to produce a
distinctive red pigment referred to as prodigiosin (Su et al.,
2016). Serratia plymuthica (S. plymuthica), Serratia rubidaea
(S. rubidaea), and Serratia nematodiphila (S. nematodiphila)
have also been reported to synthesize this pigment, while non-
pigmented strains of these species have been identified (Su et al.,
2016). In recent years, pigmented and non-pigmented Serratia
species have been recognized as a potential source of novel and
structurally diverse bioactive secondary metabolites (Soenens and
Imperial, 2019). These bioactive metabolites include the pigment
prodigiosin as well as biosurfactants (lipopeptides and
glycolipids), glucosamine derivatives, oocydin A, siderophores
(such as serratiochelin A; Figure 1A), bacteriocins, carbapenem,
althiomycin and serratin, among others (Clements et al., 2019a;
Khilyas et al., 2019). Prodigiosin and serrawettins are two of the
more extensively studied secondary metabolites due to their
diverse biological activity and application as antitumor,
antibacterial and antifungal agents (Stankovic et al., 2014;
Eckelmann et al., 2018; Clements et al., 2019a).
Prodigiosin is a red, tripyrrole pigment (family of
prodiginines) that is produced by several bacterial genera, such
as Serratia, Hahella, Streptomyces, Zooshikella, Vibrio, and
Pseudomonas, among others (Darshan and Manonmani, 2015).
Prodigiosin has a general structure of 2-methyl-3-pentyl-6-
methoxyprodiginine (Figure 1B) and is composed of three
rings referred to as pyrrolic ring A, B, and C (Hage-Hülsmann
et al., 2018; Yip et al., 2019). Research has indicated that it is
synthesized via a bifurcated pathway encoded in a pigment (pig)
gene cluster comprised of 14 genes (pigABCDEFGHIJKLMN)
(Williamson et al., 2006). In contrast, serrawettins are non-
ribosomally synthesized cyclodepsipeptides solely produced by
several members of the Serratia genus. Serrawettins are classified
as lipopeptides as they are composed of a hydrophilic peptide
moiety and a hydrophobic fatty acid moiety. Three unique
structures of serrawettins were initially identified, including
serrawettin W1 (also referred to as serratamolide A),
serrawettin W2 and serrawettin W3 (Wasserman et al., 1961;
Matsuyama et al., 1985; Matsuyama et al., 1986; Matsuyama et al.,
1992), while various analogues and homologues of serrawettin
W1 and W2 have since been described (Dwivedi et al., 2008;
Motley et al., 2016; Su et al., 2016). Serratamolide A and
homologues of this lipopeptide (including serratamolide B to
G) are comprised of a cyclic peptide moiety of two L-serine amino
acids linked to two β-hydroxy fatty acid moieties that may vary in
length (C8 to C14) of the fatty acyl chain and may be saturated or
unsaturated (Figure 1C; Dwivedi et al., 2008). In comparison,
serrawettin W2 and W3 are comprised of five amino acids linked
to one β-hydroxy fatty acid (Matsuyama et al., 1986; Matsuyama
et al., 1992).
FIGURE 1 | General structures of (A) serratiochelin A, (B) prodigiosin, (C) serratamolide and (D) glucosamine derivative (adapted from Dwivedi et al., 2008; Lee
et al., 2011; Seyedsayamdost et al., 2012). The R1 and R2 groups on the serratamolides and glucosamine derivative structures indicate the fatty acyl moieties and
these chains may vary in length and saturation (saturated, mono-unsaturated or poly-unsaturated).
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Glucosamine derivatives (also referred to as
N-butylglucosamine ester derivatives) are non-ribosomally
synthesized diacylated peptoglucosamine derivatives (Dwivedi
et al., 2008; Khilyas et al., 2019) produced by Serratia species.
They have not been extensively studied and to date only Dwivedi
et al. (2008) characterized glucosamine derivatives produced by a
pigmented S. marcescens SHHRE645 strain. The identified
glucosamine derivative homologues (A to C) were comprised
of four residues, including glucose, valine, butyric acid and a
saturated or unsaturated β-fatty acid residue of varying length
(Figure 1D). It was observed that the glucosamine derivatives
were co-produced with serratamolide homologues. Although
extensive research into the biological properties of
glucosamine derivative homologues (A to C) is still required,
Dwivedi et al. (2008) reported on the anti-mycobacterial activity
for each homologue.
To date, several analytical methods have been utilized to
elucidate the detailed structures and composition of secondary
metabolites produced by Serratia species, including mass
spectrometry (MS), liquid chromatography (LC), gas
chromatography (GC), and nuclear magnetic resonance
(NMR) (Dwivedi et al., 2008; Thies et al., 2014; Eckelmann
et al., 2018). Chromatography methods are commonly coupled
with MS for the reliable separation and identification of bioactive
compounds (Fu et al., 2019). Moreover, tandem MS analysis
allows for the detection and structural characterization of a broad
range of compounds and distinguishes between closely related
forms of the same compound produced by a bacterial strain
(Knolhoff et al., 2015). For example, a study by Eckelmann et al.
(2018) unraveled the secondary metabolic profile of a pigmented
S. marcescens strain MSRBB2 using high performance LC
(HPLC) linked to high resolution MS (HRMS) and HRMSn
analysis. The characteristic fragmentation patterns produced
by HRMSn analysis allowed for the identification and
elucidation of 33 compounds, including 7 prodiginines and 26
serratamolides (Eckelmann et al., 2018).
Recently, a novel approach has been developed to analyze large
data sets from tandem MS spectra of natural product extracts.
This approach involves the Global Natural Products Social
(GNPS) molecular network platform (http://gnps.ucsd.edu) as
an open-access tool that employs a computational algorithm to
compare the degree of similarity between tandemMS spectra and
generates a molecular network comprised of clusters of
structurally related metabolites. Thus, a visual representation
of the structural relationships between natural compounds
within crude extracts is generated, where a node within the
network represents a compound and the relatedness between
two compounds (nodes) is referred to as an edge. Moreover,
GNPS allows for the comparison of the tandemMS spectra to the
publicly available spectral library for rapid identification of
known compounds (Wang et al., 2016; Philippus et al., 2018).
Here, we present an integrated approach to identify and
structurally elucidate the naturally produced complex of
secondary metabolites of a pigmented (P1) and non-pigmented
(NP1) S. marcescens strain using reverse-phase high performance
liquid chromatography (RP-HPLC), electrospray ionization mass
spectrometry (ESI-MS), untargeted ultra-performance liquid
chromatography coupled to tandem mass spectrometry (UPLC-
MSE) and molecular networking (using the GNPS molecular
network platform) analysis. In addition, the susceptibility of a
clinical Enterococcus faecalis (E. faecalis) strain to fractions
collected during RP-HPLC analysis was evaluated using disc
diffusion assays (all fractions) and broth microdilution assays to
determine the minimum inhibitory concentration (MIC) and
minimum bactericidal concentration (MBC) of selected fractions.
MATERIALS AND METHODS
Bacterial Strains
A previous study by Clements et al. (2019b) outlined the
isolation of the P1 and NP1 S. marcescens strains from an
oil refinery effluent sample and a river water sample,
respectively as well as the molecular identification of the
strains. The two S. marcescens strains were streaked from
the glycerol stocks onto Nutrient agar (Merck,
Johannesburg, South Africa) and were incubated at 30°C for
18–24 h. The S. marcescens P1 and NP1 strains were deposited
in the South African Rhizobium Culture Collection (SARCC
no. for P1: 3059; SARCC no. for NP1: 3060). The clinical E.
faecalis S1 strain, used for the disc diffusion and MIC assays,
was streaked from the glycerol stock onto tryptone soy agar
(Biolab, Merck, Johannesburg, South Africa) supplemented
with 6 g/L yeast extract (Biolab, Merck, Johannesburg, South
Africa) (TSAYE0.6%) and was incubated at 37°C for 18–24 h.
The clinical E. faecalis S1 strain is curated and accessible in the
Water Resource Laboratory culture collection in the
Department of Microbiology at Stellenbosch University.
Production and Extraction of Secondary
Metabolites
The production and partial purification of secondary metabolites
was performed as described by Clements et al. (2019b), with slight
modifications to the scale of production (increased volume) and
the use of peptone powder in culture media (Biolab, Merck,
Johannesburg, South Africa). Briefly, seed cultures were grown
overnight by inoculating the S. marcescens P1 and NP1 strains
into 10 ml Luria Bertani broth (Biolab, Merck, South Africa) in
triplicate and incubating on a test tube rotator (MRCLAB,
London, United Kingdom) at 30°C. Each seed culture was
subsequently inoculated into a 2 L baffled flask containing
500 ml Peptone Glycerol (PG, pH 7.2 ± 0.2) broth [composed
of 5 g peptone powder and 10 ml glycerol (Promega, Wisconsin,
United States) in 1 L distilled water] in triplicate, which was
incubated on an orbital shaker (MRCLAB, London,
United Kingdom) at 30°C for 120 h at 120 rpm. Following a
5 days incubation period, the P1 and NP1 broth cultures were
centrifuged at 10,000 rpm for 20 min at 4°C to obtain the cell free
supernatant. The cell free supernatants were lyophilized and
dissolved in 70% HPLC-grade acetonitrile (Romil, Darmstadt,
Germany) in analytical quality water (milliQ water) (v/v). The
acetonitrile soluble fraction was transferred into a sterile
McCartney bottle and lyophilized. This step was repeated
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thrice to further purify the crude extracts. The triplicate crude
extracts were then pooled, lyophilized, analytically weighed and
stored at −20°C until further use.
Purification and Detection of Secondary
Metabolites
The P1 and NP1 crude extracts were subjected to RP-HPLC
(Finnigan Survey UV-VIS Plus detector, Thermo-Scientific,
Waltham, MA, United States) analysis, in the Department of
Microbiology, in order to obtain purified fractions. The
lyophilized P1 and NP1 crude extracts were dissolved in 40%
acetonitrile in milliQ water (v/v) to a concentration of 10.00 mg/
ml and were injected into a Discovery BIO Wide Pore C18 HPLC
column (10 μm, 250 × 10 mm; Sigma-Aldrich, St. Louis,
United States). Liquid chromatography was conducted with
milliQ water containing 0.1% trifluoroacetic acid (TFA; v/v;
Sigma-Aldrich, St. Louis, United States) as solution A and
acetonitrile containing 0.1% TFA (v/v) as solution B. An
isocratic flow at 40% B from 0 to 2 min for sample loading
was followed by a linear gradient from 40 to 95% B from 2 to
36 min. The column was washed for 2 min with 95% B and then
regenerated with a reversed gradient from 95 to 40% B from 38 to
45 min. Chromatography of compounds was followed by
continuous monitoring of the absorbance at 230 and 254 nm.
The absorbing peak fractions collected from the RP-HPLC
were analyzed using a Waters Synapt G2 high resolution mass
spectrometer fitted with a Z spray electrospray ionization source
(Waters Corporation, Milford, United States) at the LCMS unit at
the Central Analytical Facility (CAF, Stellenbosch University,
South Africa). For direct mass analysis, 3 µl of the sample [250 μg/
ml; dissolved in 50% acetonitrile in milliQ water (v/v)] was
injected into the ionization source at a flow rate of 0.3 ml/min.
The analytes were subjected to a capillary voltage of 2.5 kV, cone
voltage of 15 V, a source temperature of 120°C, desolvation gas
(N2) flow of 650 L/h and desolvation temperature at 275°C. Data
acquisition in the positive mode was performed byMS scanning a
second analyser through the mass to charge (m/z) range of
300–1,500 in centroid mode. The high resolution mass
calibration was done with sodium formate and in-analysis
single point lock spray calibration using leucine enkephalin
(m/z  556.2771). The ESI-MS data was processed using
MassLynx software version 4.1 (Waters Corporation, Milford,
United States). The accurate masses and molecular formula of the
detected compounds were used to search online databases, such
as Norine (https://bioinfo.lifl.fr/norine/) and PubChem (https://
pubchem.ncbi.nlm.nih.gov/), of known natural products and an
extensive literature search was conducted for the putative
identification of the metabolites.
Analysis Utilizing Untargeted
Ultra-performance Liquid Chromatography
Linked to Tandem Mass Spectrometry
In order to elucidate the structure of each of the detected
compounds, all fractions were subjected to untargeted ultra-
performance liquid chromatography coupled to tandem mass
spectrometry (UPLC-MSE) analysis at the LCMS unit at the
Central Analytical Facility (CAF, Stellenbosch University). The
RP-HPLC purified fractions obtained from the P1 and NP1 crude
extracts were prepared in 70% acetonitrile in milliQ water (v/v) to
a concentration of 250 μg/ml and were subjected to the Waters
Synapt G2 high resolution mass spectrometer linked to an
Acquity UPLC™ for UPLC-MS analysis. Three microlitres of
each fraction (1.00 mg/ml) was separated on an UPLC C18
reverse-phase analytical column (Acquity UPLC® HSS T3,
1.8 μm particle size, 2.1 × 150 mm, Waters Corporation,
Dublin, Ireland). The compound separation via UPLC was
facilitated with milliQ water containing 0.1% (v/v) formic acid
as solution A and acetonitrile containing 0.1% (v/v) formic acid as
solution B. The gradient was developed at a flow rate of 0.300 ml/
min as follows: 60% A from 0 to 0.5 min for loading, linear
gradient from 20 to 80% (B) from 0.5 to 14 min and 0–100% (B)
from 14 to 15 min. The ESI-MS instrument settings for
monitoring the chromatography were as described for the
direct mass analysis.
High resolution collisionally induced dissociation (CID)
analysis was conducted in the MSE mode (MS/MS) during the
UPLC-MS analysis and was monitored on a second MS channel.
The CID was conducted at a collision energy gradient of
20–70 eVat 1 s MS/MS scan time. Data was collected in the
second mass analyser (MS2) through m/z range of 40–1,500 in
centroid mode. The rest of the instrument settings were as
described above. The UPLC-MSE data was processed using
Mass Lynx software version 4.1 (Waters Corporation).
Molecular Networking Analysis
TheWaters RAW files for the P1 andNP1 fractions obtained after
UPLC-MSE analysis were converted into an Analysis Base File
(ABF) format using Reifycs Analysis Base File Converter before
data processing. Ion chromatogram extraction, alignment and
peak deconvolution of the ABF converted files was then
conducted using MS-DIAL software version 4.24. The aligned
results were exported as a mascot generic format (mgf) file for P1
and NP1 (Tsugawa et al., 2015). Thereafter, the mgf files for the
two strains were uploaded to the GNPS platform (http://gnps.
ucsd.edu) and a molecular network was created using the
workflow published by Wang et al. (2016). Briefly, the data
was filtered by removing all MS/MS fragment ions within
+/−17 Da of the precursor m/z. The MS/MS spectra were
window filtered by selecting only the top six fragment ions in
the +/−50 Da window throughout the spectrum. The following
parameters were then used in the workflow: precursor ion mass
tolerance was set to 0.03 Da, MS/MS fragment ion tolerance of 0.
02 Da, cosine score above 0.6 and minimum matched peaks of
ten. Further, edges between two nodes were kept in the network
only if each of the nodes appeared in each other’s respective top
10 most similar nodes. The spectra in the network were then
searched against GNPS’ spectral libraries. All matches retained
between network spectra and library spectra were required to
have a score above 0.7 and at least six matched peaks (Wang et al.,
2016). The output of the molecular network was visualized using
Cytoscape version 3.8.0. The nodes (compounds) originating
from media and solvent controls (acetonitrile) were excluded
Frontiers in Chemistry | www.frontiersin.org March 2021 | Volume 9 | Article 6338704
Clements et al. Metabolites Produced by Serratia marcescens
from the original network in order to visualize the secondary
metabolites derived from the P1 and NP1 strains.
Antimicrobial Susceptibility Testing
Disc Diffusion Assay
The lyophilized fraction stocks (obtained after RP-HPLC) were
dissolved in 100% dimethyl sulfoxide (DMSO; Sigma-Aldrich, St.
Louis, United States) to a concentration of 20.00 mg/ml (stock
concentration). Following solubility of each fraction, an aliquot of
each fraction was diluted in milliQ water to a final concentration
of 3.00 mg/ml (with a final DMSO concentration of 15%). These
aliquots (at 3.00 mg/ml) were then subjected to antimicrobial
testing using a standard disc diffusion assay as described by Das
et al. (2008) and Ndlovu et al. (2017). Briefly, the E. faecalis S1 test
strain was inoculated into 5 ml of tryptone soy broth (Biolab,
Merck, Johannesburg, South Africa) supplemented with 6 g/L
yeast extract (TSBYE0.6%) and was incubated at 37°C for 18–24 h.
Following incubation, 100 µl of the E. faecalis S1 suspension was
spread plated onto TSAYE0.6% to create a microbial lawn.
Thereafter, 6 mm filter paper discs (Oxoid, Basingstoke,
United Kingdom) were placed onto the microbial lawn using a
sterile needle and 50 µl of each fraction (3.00 mg/ml in 15%
DMSO) was pipetted directly onto the filter paper (in triplicate)
in order to create an antimicrobial disc. A negative control of
50 µl of 15% (v/v) DMSO was included and the plates were
incubated for 24 h at 37°C.
Minimum Inhibitory and Bactericidal Concentration
Fractions were selected for further antimicrobial testing based on
the results of the disc diffusion assay and the quantity of each
fraction remaining. The fraction stocks were prepared in 100%
DMSO (as outlined in 2.6.1) to 20.00 mg/ml and aliquots were
prepared and diluted to 6.00 mg/ml (DMSO concentration of
30%) using milliQ water. A serial dilution of the fractions at
6.00 mg/ml was then conducted using 30% DMSO to obtain a
concentration range of 1.50–6.00 mg/ml (DMSO concentration
of 30%). The selected fractions (at various concentrations) were
subjected to antimicrobial testing using a broth microdilution
susceptibility assay as outlined by the European Committee on
Antimicrobial Susceptibility Testing (European Communitee on
Antimicrobial Susceptibility Testing, 2018) and Magalhães and
Nitschke et al. (2013). Briefly, E. faecalis S1 was inoculated into
5 ml of TSBYE0.6% and was incubated at 37°C for 18–24 h.
Following overnight incubation, the culture was diluted to an
optical density (OD) of approximately 0.08 at 625 nm
corresponding to ∼107 colony forming units (CFU)/ml. One
hundred microlitres of each fraction (at the various
concentrations) was dispensed into the respective wells of a
Greiner CELLSTAR® 96-well culture plate (Merck,
Johannesburg, South Africa) containing 100 μl of sterile
TSBYE0.6% (resulting in a final test concentration of
0.75–3.00 mg/ml in 15% DMSO). All the wells of the
microtiter plate were inoculated with 10 μl of the bacterial
inoculum (final concentration of ∼105 CFU/ml). Sterile broth,
15% DMSO and the OD adjusted inoculum were included in the
assay as positive controls, while sterile broth with 15%DMSOwas
included as a negative control. All the tests were performed in
triplicate and the microtiter plate was incubated for 18–24 h at
37°C. Following incubation, the absorbance was measured using a
microtiter plate reader. The MIC was assigned as the lowest
concentration of the respective compounds that reduced bacterial
numbers by ≥90% (Yasir et al., 2019). The MBC was determined
as previously described by Das et al. (2008). Briefly, after the MIC
determination, the wells that showed ≥90% inhibition of growth
were identified and 20 µl of each well was spot plated onto
TSAYE0.6%. The lowest concentration showing no revival of
the test culture was recorded as the MBC.
RESULTS
Purification and Identification of Secondary
Metabolites
Reverse-phase HPLC was used to fractionate the secondary
metabolites within the P1 and NP1 crude extracts. The RP-
HPLC analysis of the P1 and NP1 crude extracts revealed n 
11 absorption peaks in the P1 crude extract and n  8 absorption
peaks in the NP1 crude extract, between 8 and 35 min. All the
collected fractions were then subjected to ESI-MS analysis to
detect potential metabolites produced by each strain. As a result, a
combined total of 21 compounds, produced by the P1 and/or NP1
strains, were detected [numbered as compounds 1–21 and
arranged according to the retention time (Rt), Supplementary
Table S1. The positive mode ESI-MS analysis of each collected
fraction obtained from the P1 crude extract revealed a profile with
major molecular ions at m/z 430.1609, 324.2073, 515.3331,
557.3804, 541.3485, 543.3644, 571.3931, and 559.3953
(compounds 1, 2, 4, 7, 9, 13, 18, and 14, respectively). The
ESI-MS analysis of the NP1 crude extract revealed a similar
profile with the major molecular ions of m/z 430.1609, 515.3331,
557.3804, 541.3485, 543.3644, 559.3953, and 585.4117
(compounds 1, 4, 7, 9, 13, 14, and 16, respectively). The
corresponding sodium and potassium adducts of the
compounds from the P1 and NP1 fractions were also detected
(Supplementary Table S1). It should be noted that several
compounds co-eluted with the major compounds (higher
molecular ion signal) (Supplementary Table S1). Due to the
co-elution of presumptive known (n  12) and unknown (n  9)
compounds detected in the P1 and/or NP1 crude extracts, UPLC-
MSE coupled with molecular networking analysis was used to
cluster structurally similar compounds and elucidate the putative
structures of the unknown compounds and facilitate the
confirmation of the known structures.
Molecular Networking Analysis
The fractions obtained after RP-HPLC of the secondary
metabolites extracted from the P1 and NP1 strains were
subjected to UPLC-MSE analysis and the raw MSE data was
used to generate a molecular network. Analysis of the
molecular network revealed four clusters (Figures 2, 3, 5),
including families of serratiochelin (comprised of five nodes)
and prodigiosin (comprised of two nodes) that were identified
using the GNPS and MS-DIAL libraries, respectively, and two
unidentified F1 (comprised of 15 nodes) and F2 (comprised of 22
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nodes) families that did not correspond to compounds within the
GNPS and MS-DIAL libraries. In general, the majority of the
metabolites (nodes) clustered in the F1, F2 and serratiochelin
families and were detected in both P1 and NP1 strains; however,
only the P1 strain produced compounds in the prodigiosin
cluster. The entire network was formed by 55 nodes, including
11 individual nodes.
UPLC-MSE Analysis
Following molecular networking, the structural elucidation of the
four distinct metabolite clusters produced by the S. marcescens P1
and NP1 strains was conducted by analyzing the fragmentation
profiles of the UPLC-MSE data. The identified serratiochelin
cluster (Figure 2) revealed a node with m/z 430.1609
[C21H23N3O7 + H]
+ (compound 1) corresponding to the peak
observed at 3.76 min in the UPLC-MSE data for the P1 and NP1
strains (Table 1; Supplementary Figure S1). The fragmentation
pattern of 1, which was observed using UPLC-MSE, corresponded
to the serratiochelin A (also referred to as serranticin)
structure (Kuo et al., 2011; Seyedsayamdost et al., 2012).
The prodigiosin cluster (Figure 2) revealed a node with m/z
324.2073 [C20H25N3O+ H]
+ (compound 2) corresponding to
the peak observed at 8.48 min in the UPLC-MSE data for the P1
strain (Table 1; Supplementary Figure S2). The
fragmentation pattern of 2, which was observed using
UPLC-MSE, corresponded to the prodigiosin structure (Lee
et al., 2011; Su et al., 2016). The fragmentation profiles and
structural elucidation of the compounds detected in clusters F1
and F2 will be discussed according to each metabolite family
(cluster). A summary of the UPLC-MSE data for the
metabolites within these clusters produced by the P1 and
NP1 strains is presented in Tables 1, 2 and Supplementary
Figures S22, S23, and the structures of the known metabolites
and putative structures of the unknown compounds produced
by the P1 and NP1 strains are depicted in Figures 3, 5 and
Supplementary Figures S3–S21.
FIGURE 2 |Molecular network of the secondary metabolites produced by the S. marcescens P1 and NP1 strains generated using the UPLC-MSE data. Nodes are
labeled with the correspondingm/z values (detected in the positive mode) and respective strain colors are indicated in the node color key. The four clusters are labeled
with either the corresponding compound family name detected using GNPS or MS-DIAL library search, or F1 and F2 corresponding to metabolite clusters that were not
identified using the library searches.
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Structural Elucidation of Serratamolide Homologues
The molecular network of the F1 cluster and corresponding
structures for the known and novel compounds in the F1
cluster are presented in Figure 3. The F1 cluster (Figure 3)
revealed nodes with m/z 515.3331 [C26H46N2O8 + H]
+
(compound 4), 541.3485 [C28H48N2O8 + H]
+ (compound 9),
543.3644 [C28H50N2O8 + H]
+ (compound 13), 561.3749
[C28H52N2O9 + H]
+ (compound 6), 559.3600 [C28H50N2O9 +
H]+ (compound 3), and 571.3931 [C30H54N2O8 + H]
+
(compound 18), which corresponded to peaks observed in the
UPLC-MSE data for the P1 and NP1 strains (Table 1;
Supplementary Figures S3–S8, S22). In addition, the F1
cluster (Figure 3) revealed a node with m/z 587.3908
[C30H54N2O9 + H]
+ (compound 11) corresponding to the
peak observed at 13.76 min in the UPLC-MSE data for the
NP1 strain (Table 1; Supplementary Figures S9, S22). The
fragmentation profiles of these seven compounds (3, 4, 6, 9,
11, 13, and 18) correspond to cyclic or open-ring serratamolide
homologues that have previously been reported (Dwivedi et al.,
2008; Eckelmann et al., 2018).
Compound 4was thus comprised of two serine residues (cyclic
peptide moiety) coupled to two saturated hydroxydecanoic acyl
groups (C10) (Figure 3) confirming the identity of the compound
as serratamolide A (Dwivedi et al., 2008). In addition, 18 was
comprised of two serine residues (cyclic peptide moiety) linked to
two saturated hydroxydodecanoic acyl groups (C12), which
corresponded to a serratamolide homologue reported by
Eckelmann et al. (2018) (Figure 3). In contrast, 9 and 13 were
comprised of two serine residues (cyclic peptide moiety) coupled
to a 3-hydroxydecanoic acyl (C10) and a hydroxydodecanoic acyl
(C12) (Figure 3). Compound 13 thus corresponded to the
previously described serratamolide C (Dwivedi et al., 2008).
However, compound 9 had a double bond in the
hydroxydodecanoic acyl (C12:1) residue (Figure 3) confirming
the structure as serratamolide B (Dwivedi et al., 2008). The double
bond position was putatively placed at the C5 position (from the
CO group) of the fatty acyl chain, as this corresponded to the
FIGURE 3 | The molecular network of cluster F1 (magnified) with the corresponding structures of known and unknown serratamolide homologues [previously
identified by and adopted from Dwivedi et al. (2008) and Eckelmann et al. (2018)] detected in the P1 and NP1 crude extracts identified using UPLC-MSE analysis. Red
nodes  metabolites produced by the P1 strain; Blue nodes  metabolites produced by the NP1 strain; Purple nodes  metabolites produced by both P1 and NP1
strains.
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position previously reported in literature (Eckelmann et al.,
2018). Compounds 3 and 6 had identical fatty acyl chain
lengths as serratamolide B and C, respectively, however, the
addition of a hydroxyl group, based on the experimental
molecular formula (elemental composition) predicted using
the MassLynx 4.1 software package, in the compound
suggested that both lipopeptides were open-ring structures and
corresponded to the fragmentation pattern of the previously
described open-ring serratamolides B and C (Eckelmann et al.,
2018) (Figure 3). Similarly, 11 was comprised of one serine
residue coupled to one saturated hydroxydodecanoic acyl (C12)
and one serine residue coupled to one unsaturated
hydroxydodecanoic acyl (C12:1). However, the addition of a
hydroxyl group [based on the experimental molecular
formula (elemental composition)] in the compound
suggested that the lipopeptide was an open-ring structure
and corresponded to the fragmentation pattern previously
described by Eckelmann et al. (2018) (Figure 3). Overall, it
is proposed that this compound group is comprised of four
residues, including a peptide moiety of two serine residues
(cyclic or open-ring) attached to two fatty acyl residues
(varying in length and presence or absence of double
bonds). From the described serratamolides it was assumed
that the compounds described above contain L-serine residues
and D-3-hydroyxy-fatty acyl residues.
The compound with m/z 585.374 [C30H52N2O9 + H]
+
(compound 8) did not cluster in the molecular network;
however, it was detected at 12.46 min in the UPLC-MSE data
for the NP1 strain (Table 1; Figure 4A; Supplementary Figures
S10, S22). The fragment with m/z 567.368 corresponded to a
product of dehydration (removal of H, OH). A major fragment at
m/z 284.185 was then observed, representing a dehydrated serine
residue linked to an unsaturated hydroxydodecanoic acid (C12:1).
In addition, the dehydration product of them/z 284.185 fragment
was detected at m/z 266.176. Similar to the previously described
open-ring structures, the addition of a hydroxyl group [based
on the experimental molecular formula (elemental composition)]
in the compound suggested that the lipopeptide was an open-
ring structure; however, this compound has not previously
been reported in literature or databases (Norine and
PubChem). The novel 8 homologue was thus proposed to
comprised of two L-serine residues coupled to two unsaturated
FIGURE 4 | The fragmentation profiles and proposed structures of (A) open-ring serratamolide 585 (compound 8) and (B) glucosamine derivative J
(compound 20).
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D-3-hydroxydodecanoic acyl groups (C12:1), correlating to
described serratamolides (Figure 4A).
The F1 nodes with m/z 537.3147, 563.3290, 565.3455,
581.3405 and 609.3735 were found in the UPLC-MSE data and
corresponds to the sodiated adducts of the compounds 4, 9, 13,
14, 3, and 11, respectively, (Supplementary Table S1). In
contrast, no structures were established for the F1 nodes with
m/z 531.365 and 575.391.
Structural Elucidation of Glucosamine Derivatives
The molecular network of the F2 cluster and corresponding
structures for the known and novel compounds in the F2
cluster are presented in Figure 5. The F2 cluster (Figure 5)
revealed nodes with m/z 585.4117 [C31H56N2O8 + H]
+
(compound 16) and 559.3953 [C29H54N2O8 + H]
+ (compound
14) corresponding to the peaks observed in the UPLC-MSE data
for the P1 and NP1 strains, while m/z 573.4136 [C30H56N2O8 +
H]+ (compound 19) corresponded to a peak observed in the
UPLC-MSE data for the P1 strain (Table 2; Supplementary
Figures S11–S13, S23). The fragmentation profiles of these
three compounds (14, 16, and 19) correspond to glucosamine
derivative homologues that have previously been reported
(Dwivedi et al., 2008). For all three compounds, the two major
fragments were linked via an anomeric C-O bond between the
hexose and valine amino acid residues. Therefore, 16 was
proposed to be comprised of a hexose residue linked to
butyric acyl group, which in turn was coupled to a valine
residue linked to an unsaturated C16:1 fatty acid chain
correlating to a previously described compound, glucosamine
derivative A (Dwivedi et al., 2008) (Figure 5). The hexose was
assumed to be glucose and the double bond within the fatty acyl
chain of glucosamine derivative A was assumed to be a cis double
bond corresponding to the structure previously described in
literature (Dwivedi et al., 2008). Compound 19 was also
proposed to be comprised of a glucose residue linked to a
butyric acyl group, coupled to a valine residue linked to a
saturated C15 fatty acid chain, thus correlating with the
structure of glucosamine derivative B as described by Dwivedi
TABLE 1 | Summary of the serratamolide homologues, prodigiosin and serratiochelin A detected in the crude extracts obtained from S. marcescens P1 and NP1 that were































N/A C21H23N3O7 430.1609 429.1530 429.1536 1.49 137, 192, 194,
211, 220, 250,
277, 294

















11.49 4 Serratamolide A/
Serrawettin W1
C10 + C10 C26H46N2O8 515.3331 514.3252 514.3254 0.47 212, 240, 258,
276, 469,
487, 497
NP1 12.46 8 eOpen-ring
serratamolide
585









13.06 13 Serratamolide C C10 + C12 C28H50N2O8 543.3644 542.3565 542.3567 0.44 212, 240, 258,
268, 276, 286,
304, 515, 525
NP1 13.76 11 Open-ring
serratamolide
587







C12 + C12 C30H54N2O8 571.3931 570.3852 570.3880 4.98 222, 240, 268,
286, 304,
525, 553
aExperimental monoisotopic Mr of compound was calculated using the Time-of-Flight (TOF) transform function in the MassLynx 4.1 software package.
bTheoretical monoisotopic Mr of compound was calculated using ChemDraw Ultra 12.0 software package.
cMass error in ppm  (Theoretical Mr − Experimental MrTheoretical Mr ) × 106




Bold entries correspond to compound numbers.
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et al. (2008) (Figure 5). Finally, 14 had a structure similar to the
other two glucosamine derivatives. Compound 14 was also
proposed to be comprised of a glucose residue linked to
butyric acid, a valine residue linked to a saturated C14 fatty
acid chain and thus the structure correlated to the
glucosamine derivative C (Dwivedi et al., 2008) (Figure 5).
Overall, it is proposed that this compound group is comprised
of four residues, namely glucose, valine, butyric acid and a
saturated or unsaturated β-fatty acid of varying length (C14
to C16).
Other F2 nodes (Figure 5) at m/z 557.3804 [C29H52N2O8 +
H]+ (compound 7), 583.3947 [C31H54N2O8 + H]
+ (compound
15) and 589.4056 [C30H56N2O9 + H]
+ (compound 12) had
similar fragmentation profiles to 14, 16, and 19 and
corresponded to peaks observed in the UPLC-MSE data for P1
and NP1 strains (Table 2; Supplementary Figures S14–S16). In
addition, F2 nodes at m/z 575.3902 [C29H54N2O9 + H]
+
(compound 5), 587.4268 [C31H58N2O8 + H]
+ (compound 21),
and 599.4265 [C32H58N2O8 + H]
+ (compound 17) also had
similar profiles to glucosamine derivative A to C and
corresponded to peaks observed in the UPLC-MSE data for
the P1 strain, while another node at m/z 545.3787
[C28H52N2O8 + H]
+ (compound 10) corresponded to peaks
observed in the UPLC-MSE data for the NP1 strain (Table 2;
Supplementary Figures S17–S20, S23). The cleavage of all seven
compounds at the anomeric C-O bond resulted in two major
fragments for each compound. Similar to the previously
described known compounds 14, 16, and 19, each
compound had a major fragment of m/z 232.116
corresponding to the glucose/hexose residue linked to
butyric acid, and dehydration products of the m/z 232.116
fragment were observed at m/z 214.107 and 196.097.
Compounds 10 and 21 had a second major fragment of m/z
314.272 and 356.316, which corresponded to a valine residue
linked to a saturated C13 and C16 fatty acyl chain, respectively.
In addition, 7, 15, and 17 had a second major fragment of m/z
326.267, 352.282, and 368.316 which corresponded to a valine
residue linked to an unsaturated C14:1, C16:2 and C17:1 fatty acid
chain, respectively. Finally, 5 and 12 had a major fragment of
m/z 344.280 and 358.296, which corresponded to a valine
residue linked to a saturated C14 and C15 fatty acyl chain
with an additional hydroxyl group in the fatty acyl residue. The
presence of the hydroxyl group within the fatty acid moiety
was further confirmed, as the loss of a hydroxyl group was
observed within the fragmentation profile for both m/z
344.280 and 358.296 fragments, including m/z 326.269 and
340.286, respectively. In addition, the experimental molecular
formula (elemental composition) predicted by the MassLynx
4.1 software package provided further indication of the
addition of the hydroxyl group for both 5 and 12 (Table 2).



























P1 11.44 5 eGlucosamine
derivative D






C14:1 C29H52N2O8 557.3804 556.3722 556.3724 -0.31 196, 214, 232,
326, 348
NP1 12.67 10 eGlucosamine
derivative F
























C16:1 C31H56N2O8 585.4117 584.4035 584.4037 -0.10 196, 214, 232,
354, 376
P1 15.69 19 Glucosamine
derivative B
C15 C30H56N2O8 573.4136 572.4034 572.4037 -3.42 196, 214, 232,
342, 364
P1 16.01 17 eGlucosamine
derivative I
C17:1 C32H58N2O8 599.4265 598.4203 598.4193 1.24 196, 214, 232,
368, 390
P1 16.28 20 eGlucosamine
derivative J
C16:1 C33H58N2O9 627.4192 626.4114 626.4142 4.69 256, 274, 296,
354, 376
P1 16.50 21 eGlucosamine
derivative K
C16 C31H58N2O8 587.4268 586.4187 586.4193 0.55 196, 214, 232,
356, 378
aExperimental monoisotopic Mr of compound was calculated using the TOF transform function in the MassLynx 4.1 software package.
bTheoretical monoisotopic Mr of compound was calculated using ChemDraw Ultra 12.0 software package.
cMass error in parts per million (ppm)  (Theoretical Mr − Experimental MrTheoretical Mr ) × 106
dTheoretical molecular formula of compound was calculated using ChemDraw Ultra 12.0 software package and experimental molecular formula was confirmed using the MassLynx 4.1
software package.
eNovel glucosamine derivative homologues.
Bold entries correspond to compound numbers.
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Typically, MS analysis is used in conjunction with other
analytical methods, such as NMR, to determine the position of
double bonds and hydroxyl groups within a structure
(Eckelmann et al., 2018). However, the majority of the
glucosamine derivative compounds were obtained in low
quantities and could thus not be subjected to NMR analysis. A
cis configuration was thus proposed for the double bonds in the
fatty acid chain of the various unknown compounds, as the
geometric isomerism of a double bond is typically a cis
configuration in natural fatty acids (Kobelnik et al., 2018).
Therefore, we propose that 7, 15, and 17 were novel
glucosamine derivative homologues comprised of a glucose
residue linked to butyric acyl, coupled to a valine residue
linked to an unsaturated C14:1, C16:2, C17:1 fatty acyl chain,
respectively (Figure 5). Compounds 10 and 21 were
proposed to be comprised of a glucose residue linked to a
butyric acyl, coupled to a valine residue linked to a saturated
C13 and C16 fatty acyl chain, respectively (Figure 5). Finally, 5
and 12 were also proposed to be comprised of a glucose residue
linked to butyric acyl group, coupled to a valine residue linked
to a saturated C14 and C15 fatty acyl chain, respectively;
however, the fatty acyl chain had an additional hydroxyl
group (Figure 5). Overall, this compound group, correlating
to the previous group, were proposed to be comprised of four
residues, including glucose, valine, butyric acid and a fatty acid
(Figure 5). Following an extensive literature and database
search (Norine and PubChem), the identified structures (5,
7, 10, 12, 15, 17, and 21) and fragmentation patterns did not
correspond to previously identified glucosamine derivatives
(N-butylglucosamine ester derivatives) and are hypothesized
to be novel glucosamine derivatives homologues. The F2 nodes
with m/z 607.3924, 581.3781, 579.3623, and 567.3618 were
found in the UPLC-MSE data and corresponded to the sodiated
adducts of compounds 16, 14, 7, and 10, respectively,
(Supplementary Table S1). No structures were elucidated
for the F2 nodes with m/z 513.316, 543.363, 555.367,
569.381, and 601.407.
In contrast, to the above mentioned glucosamine
derivatives, an individual node (Figure 2) with m/z
627.4192 [C33H58N2O9 + H]
+ (compound 20) exhibited a
unique fragmentation profile and corresponded to a peak at
16.28 min observed in the UPLC-MSE data for the P1 strain
(Table 2; Figure 4B; Supplementary Figures S21, S23). The
fragmentation profile was unique as 20 did not have a major
fragment of m/z 232.116 (corresponding to a hexose residue
linked to butyric acyl group) that was common in all of the
previously described glucosamine derivatives. Instead, a major
fragment at m/z 274.129 was observed, which suggested a
modification in the fragment corresponding to the hexose
and butyric acyl moiety (Figure 4B). The major fragment at
m/z 274.129 potentially corresponded to a hexose residue
linked to an oxo-hexanoic acyl (rather than a butyric acyl),
and a dehydration product of the m/z 274.129 fragment was
observed at m/z 256.117. Furthermore, a second major
FIGURE 5 | The molecular network of cluster F2 (magnified) with the corresponding structures of known and unknown glucosamine derivative homologues
[previously identified by and adopted fromDwivedi et al. (2008)] detected in the P1 and NP1 crude extracts identified using UPLC-MSE analysis. Red nodes metabolites
produced by the P1 strain; Blue nodes  metabolites produced by the NP1 strain; Purple nodes  metabolites produced by both P1 and NP1 strains.
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fragment of m/z 354.302 was observed, which corresponded to
an unsaturated C16:1 fatty acid chain. In comparison to the
glucosamine derivative A (16) which also had an unsaturated
C16:1 fatty acid chain, this glucosamine derivative had an
additional C2H3O based on the experimental molecular
formula (elemental composition) predicted using the
MassLynx 4.1 software package. It is thus feasible that oxo-
hexanoic acid was incorporated into the glucosamine
derivative instead of butyric acid. In addition, 20 did not
cluster with the glucosamine derivatives in the molecular
network; rather, the compound formed an individual cluster
and this further suggests the reduced relatedness of this
compound to the glucosamine derivatives. Although NMR
is required to confirm the structure, the putative novel
congener of 20 was proposed to consist of glucose, oxo-
hexanoic acid, valine and an unsaturated C16:1 fatty acid
chain, which is distinctive from that of the previously
described glucosamine derivatives (Figure 4B).
Antimicrobial Activity
The bioactivity of the secondary metabolites produced by the P1
and NP1 strains was then investigated using disc diffusion, MIC
and MBC assays. All the fractions collected during RP-HPLC
analysis were subjected to antimicrobial testing using a disc
diffusion assay against E. faecalis S1. It was found that E.
faecalis S1 was susceptible (diameter range of 9.3 ± 2.1 to
19.3 ± 1.5 mm) to the fractions corresponding to the major
compounds (higher molecular ion signal) 4, 9, 13, 7, 14, and 16
(for both P1 and NP1), and the fraction of compound 2 collected
fromP1 crude extract (results not shown). Thereafter, theMIC and
MBC assays were performed using five fractions (selected based on
activity and quantity available), including fractions of the major
compounds (higher molecular ion signal) 2, 4, 9, 13, and 16. A
summary of the MIC and MBC assay results are outlined in
Table 3. It was observed that all three serratamolides (4, 9, and
13) (identified as outlined in Structural Elucidation of
Serratamolide Homologues) exhibited identical activity against E.
faecalis S1 with a MIC of 3 mg/ml and MBC of >3 mg/ml. In
comparison, glucosamine derivative A (compound 16; identified as
outlined in Structural Elucidation of Glucosamine Derivatives) was
found to have a lower MIC and MBC of 0.75mg/ml and 3 mg/ml,
respectively. Overall, however, the lowest MIC and MBC recorded
against E. faecalis S1 was observed for prodigiosin (compound 2;
identified as outlined inUPLC-MSE Analysis), at <0.75 and 1.5 mg/
ml, respectively, (Table 3).
DISCUSSION
Untargeted Metabolomics: UPLC-MSE and
Molecular Networking Analysis
This work reports on the identification of four molecular families
of secondary metabolites associated with Serratia species,
including serratiochelin A (1), prodigiosin (2), serratamolide
homologues (3, 4, 6, 8, 9, 11, 13, and 18) and glucosamine
derivative congeners (5, 7, 10, 12, 14–17, and 19–21) (refer to
Figures 2–5). The structures of prodigiosin and serratiochelin A
have previously been elucidated, where prodigiosin was described
as a tripyrrole red pigment with an alkyl substituent (Figure 1A;
Lee et al., 2011) and serratiochelin A was described as a low-
molecular weight siderophore with high affinity for iron
(Figure 1B; Khilyas et al., 2019). The structure of several of
the serratamolide and glucosamine derivative metabolites
detected in the current study has previously been elucidated,
with serratamolides generally described as lipopeptides of two
L-serine residues (cyclic or open-ring) linked to two fatty acid
chains (Figure 1C) and glucosamine derivatives described as
glucose amines consisting of glucose, valine, a fatty acid chain and
butyric acid (Figure 1D; Dwivedi et al., 2008; Eckelmann et al.,
2018). Moreover, based on their characteristic fragmentation
patterns, as observed in the UPLC-MSE data, eight
serratamolides (including the putative structure of a novel
open-ring serratamolide homologue) and 11 glucosamine
derivatives (including the putative structures of eight novel
glucosamine derivative congeners) were identified in this study
and their structures were elucidated.
It is well-known that certain bacteria naturally produce
various lipopeptide congeners which vary in fatty acid chain
length, fatty acyl saturation or in the amino acyl residues of the
peptide moiety (Das et al., 2008). This was similarly observed in
the current study as the identified serratamolides, comprised of
two L-serine residues linked to two fatty acyl residues, varied in
the length (C10 to C12) and the presence or absence of double
bonds (saturated or mono-unsaturated) in the fatty acyl chains
and cyclization (open-ring or cyclic) of the peptide moiety. The
glucosamine derivative congeners, comprised of glucose, valine,
butyric acyl (or oxo-hexanoic acyl for 20) and a fatty acyl residue,
similarly varied in the length (C13 to C17), as well as the presence
or absence of double bonds (saturated or unsaturated) or a
hydroxyl group in the β-fatty acyl residue. During UPLC-MSE
analysis, the elution time (Rt) of the serratamolide and
glucosamine derivative homologues was, as expected,
TABLE 3 | Minimum inhibition and bactericidal concentrations of selected fractions against the clinical E. faecalis S1 stain.
Compound no Proposed identification (fatty
acid chain length)
Purity MIC (mg/ml) MBC (mg/ml)
4 Serratamolide A (C10 + C10) 72% 3 >3
9 Serratamolide B (C10 + C12:1) 81% 3 >3
13 Serratamolide C (C10 + C12) 75% 3 >3
16 Glucosamine derivative A (C16:1) 80% 0.75 3
2 Prodigiosin 80% <0.75 1.5
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dependent on the length of the β-hydroxy fatty acid chains of the
compound. For instance, the serratamolides with shorter
saturated fatty acid moieties, such as serratamolide A (C10 +
C10) (4), eluted from the column before the serratamolides with
longer saturated fatty acid moieties, such as serratamolide 571
(C12 + C12) (18) (refer to Table 1; Supplementary Figure S22). It
was also observed that the Rt of the serratamolide and
glucosamine derivative homologues was dependent on the
saturation or unsaturation of the fatty acid moieties, for
instance, as the unsaturated glucosamine derivative A (16)
(C16:1) eluted before the corresponding saturated novel
glucosamine derivative K (21) homologue (C16) with the same
residues and fatty acid chain length (refer to Table 2;
Supplementary Figure S23). Previous research has indicated
that the presence and position of a double bond within the
fatty acyl chain influences the Rt of a compound (Takashima
et al., 2018) and the retention time of a mono-unsaturated fatty
acid is reduced to that of the equivalent saturated fatty acid with
two carbon units. A cis double bond causes a kink in the chain and
reduces the actual molecular length by nearly two carbon units,
thereby resulting in the elution of a C18:1 fatty acid just after a C16
fatty acid (Plattner et al., 1977; Takashima et al., 2018). It has also
been reported that an open-chain lipopeptide is retained in the
column for a shorter time period than the corresponding cyclic
lipopeptide due to the increased polarity of the compound (due to
the addition of the terminal COOH group) (Qiu et al., 2019),
which clarifies for example, why the cyclic serratamolide C (C10 +
C12) (13) eluted from the column after the open-chain
serratamolide 561 (C10 + C12) (6) with the same fatty acid
chain length. Furthermore, it was observed that the
glucosamine derivatives with an additional hydroxyl group
within the fatty acyl moieties were retained in the column for
a shorter time period than the corresponding glucosamine
derivative without a hydroxyl group, due to the increased
polarity of the compound. For instance, the glucosamine
derivative C (C29H54N2O8; 14) with a C14 fatty acyl chain
eluted from the column after the corresponding novel
glucosamine derivative D homologue (C29H55N2O9; 5) with a
C14 fatty acyl chain that has an additional hydroxyl group.
Overall, it was observed that the serratamolide and
glucosamine derivative homologues separated as expected
according to hydrophobicity (fatty acyl chain length) and
chain saturation.
Secondary Metabolic Profile of the S.
marcescens P1 and NP1 Strains
Clements et al. (2019b) previously identified the secondary
metabolites produced by the P1 and NP1 strains using UPLC-
MS analysis, which proposed that the P1 strain produced
prodigiosin and serratamolides (A, B, C, and E), while the
NP1 strain produced glucosamine derivative A and
serratamolides (A, B, C, and E). The use of RP-HPLC and
UPLC-MSE analysis in the current study revealed that the P1
strain produced four metabolic classes, including prodigiosin,
serratiochelin A, serratamolide homologues (n  6) and
glucosamine derivative congeners (n  10), while NP1
produced three metabolic classes, including serratiochelin
A, serratamolide homologues (n  8) and glucosamine
derivative congeners (n  6). It is hypothesized that the
combination of RP-HPLC and UPLC-MSE analysis was an
effective approach to identify the minor metabolic constituents
and elucidate the microbial metabolic profile of the
environmental Serratia strains.
Genetically, secondary metabolites are synthesized by a
number of gene clusters that can be identified using a
bioinformatics approach (Romano et al., 2018). Certain gene
clusters involved in secondary metabolism [such as non-
ribosomal peptide synthetase (NRPS) gene clusters] may not
be expressed under laboratory conditions and may be
considered as “silent” gene clusters (Bode et al., 2002). Minor
alterations in the cultivation conditions of a particular strain may,
however, trigger the expression of the “silent” gene clusters and
may allow for the discovery of novel small molecules (Bode et al.,
2002). This phenomenon is known as the “one strain many
compounds” (OSMAC) approach, which indicates that a single
strain can produce various metabolites when grown under
different media composition and cultivation conditions,
leading to the activation of the “silent” metabolic pathways
within the genome of the microbial strain (Bode et al., 2002;
Romano et al., 2018). When comparing the culture conditions of
Clements et al. (2019b) to the culture conditions employed in the
current study, an increased production scale (from 100 ml to
1,500 ml) in baffled flasks, as well as the change in media
components (from bactopeptone to peptone powder) was
applied. Thus, while the combination of RP-HPLC and
UPLC-MSE analysis may have contributed to the detection
of the minor metabolites; it is hypothesized that the altered
culture conditions and media composition employed, may
have activated “silent” NRPS clusters (such as the
glucosamine derivatives in the P1 strain and the
serratiochelin in both strains), thereby increasing the
metabolic constituents produced by both the pigmented and
non-pigmented S. marcescens strains.
Although genome mining of the P1 and NP1 strains was not
within the scope of this study, Khilyas et al. (2019) sequenced the
genome of a pigmented S. marcescens SM6 strain and used the
antiSMASH 5.0 prediction tool to identify biosynthetic gene
clusters involved in secondary metabolism within the strain.
The authors identified five biosynthetic gene clusters involved
in secondary metabolite production, including gene clusters
responsible for the production of two siderophores
(serratiochelin and chrysobactin), a thiopeptide, a
serratamolide and a glucosamine derivative (Khilyas et al.,
2019). It is possible that the P1 and NP1 strains possess
similar NRPS gene clusters as both strains were able to
produce serratiochelin, serratamolides and glucosamine
derivatives. In addition, the bifurcated biosynthetic pathway
responsible for the production of prodigiosin was additionally
activated in the P1 strain (Lee et al., 2011). Following an extensive
literature search, and to the best of the author’s knowledge, this is
the first report of the co-production of all four secondary
metabolic classes (including prodigiosin, serratiochelin A,
serratamolides and glucosamine derivatives) by a Serratia strain.
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Antimicrobial Activity
Results from this study indicated that prodigiosin (2),
serratamolide A (4), B (9), and C (13) homologues and
glucosamine derivative A (16) and C (14) homologues, as well
as the novel glucosamine derivative E (7) homologue exhibited
activity against a clinical Gram-positive bacterial strain. The MIC
and MBC assays further revealed that serratamolide A (4), B (9),
and C (13) exhibited identical activity against E. faecalis S1,
suggesting that the presence of a double bond or the increased
length of one of the two fatty acid chains from C10 to C12
exhibited no additional antimicrobial potency against the
Gram-positive strain. In comparison, glucosamine derivative A
(16) was found to exhibit a lowerMIC andMBC in comparison to
the serratamolides. This indicates that E. faecalis S1 was more
susceptible to the glucosamine derivative A (16) than the
serratamolides. Overall, however, E. faecalis S1 was found to
be the most susceptible to prodigiosin (2), as a lower MIC and
MBC was obtained against the clinical strain in comparison to
glucosamine derivative A (16) and the serratamolides (4, 9,
and 13).
The potent activity of prodigiosin corresponds to previous
research that similarly recorded activity of this pigmented
compound against Gram-positive bacteria such as
Staphylococcus aureus (S. aureus) and Bacillus subtilis (B.
subtilis) (Darshan and Manonmani, 2015). It has also been
suggested that prodigiosin is a hydrophobic stressor that
disrupts the cell membrane and results in the leakage of
intracellular products, such as K+ ions, amino acids, sugars
and proteins (Suryawanshi et al., 2016). Furthermore,
prodigiosin may interfere with cellular respiration and protein
and ribosomal ribonucleic acid synthesis (Danevčič et al., 2016a;
Danevcic et al., 2016b). Serratamolide A has similarly been
reported to display activity toward Gram-positive bacteria,
such as S. aureus strains (Kadouri and Shanks, 2013). It has
additionally been reported that serratamolide A (serrawettin W1)
increased the rate of movement of K+ and H+ across the
membrane of S. aureus at a concentration of 10 μg/ml, while
no leakage of “260 nm-absorbing products” (such as nucleic
acids), membrane permeability or cell growth inhibition was
observed at this concentration (Deol et al., 1973). Currently,
one study has reported on the antimicrobial activity of
glucosamine derivative homologues (A to C) toward
Mycobacterium diernhoferi; however, little is known about the
mechanism of action of these metabolites (Dwivedi et al., 2008).
Moreover, Hage-Hülsmann et al. (2018) described the enhanced
antimicrobial activity of serrawettin W1 (serratamolide A) and
prodigiosin in combination, in comparison to the individual
bioactive metabolites, against Corynebacterium glutamicum.
The authors hypothesized that the co-production of
serrawettin W1 and prodigiosin may provide a competitive
advantage to the producing strain due to the increased
bioactive potency, while also aiding in the colonization and
biofilm development of the producing strain by inhibiting or
delaying the growth of competing microorganisms. Thus, while
extensive research is required to investigate the ecological role of
co-producing prodigiosin, serratamolides and glucosamine
derivatives; the combined production of these bioactive
metabolites by S. marcescens may provide a competitive
advantage to the producing strain (Darshan and Manonmani,
2015; Hage-Hülsmann et al., 2018). Moreover, as indicated in
Clements et al. (2019b), the metabolites in the P1 strain may
exhibit a higher antimicrobial effect in comparison to the
metabolites in the NP1 strain, as the secondary metabolites in
the P1 crude extract were effective against 81% of the test
microbial organisms, in comparison to the 67% antimicrobial
efficacy recorded for the NP1 strain.
CONCLUSION
The use of RP-HPLC for chromatographic fractionation, high
resolution ESI-MS, UPLC-MSE and molecular networking
analysis allowed for the identification and elucidation of 21
secondary metabolites (combined total for P1 and NP1
strains), including serratamolide homologues, glucosamine
derivative homologues, prodigiosin (P1) and serratiochelin A.
Moreover, the putative structure of an open-ring serratamolide
homologue and putative structures of eight novel glucosamine
derivative congeners were elucidated. The structural relatedness
of the novel open-ring serratamolide and glucosamine derivative
congeners to the known serratamolides and glucosamine
derivatives, respectively, was revealed using molecular
networking and fragmentation patterns of the UPLC-MSE
data. This approach thus proved vital for metabolite
identification and characterization. The identified metabolic
families exhibited structural diversity and well-ordered
chromatographic behaviors due to structural modifications of
fatty acid chain lengths, open-ring or cyclic structures and the
degree of saturation (saturated or mono-unsaturated) of the fatty
acid chain. Moreover, seven fractions collected during RP-HPLC,
with major molecular ions corresponding to prodigiosin (2),
serratamolide A (4), B (9), and C (13) homologues and
glucosamine derivative A (16), C (14), and E (7) homologues,
displayed antimicrobial activity against the clinical E. faecalis S1
strain using the disc diffusion assay. However, the MIC and MBC
assays revealed that the three serratamolides [A (4), B (9), and C
(13)] exhibited the lowest antimicrobial potency (same MIC and
MBC values for all three) of the metabolites tested, and
highlighted that presence of a double bond or the change in
length of a fatty acid chain (C10 to C12) of the serratamolides
provided no additional antimicrobial potency against the
Gram-positive strain. Prodigiosin (2) however, exhibited the
greatest antimicrobial potency, followed by glucosamine
derivative A (16). This study thus highlights the importance
of Serratia species as a source of novel antimicrobial
compounds for potential therapeutic application. It is
recommended that future research investigate the mode of
action and synergism of the bioactive secondary metabolites
produced by these two S. marcescens strains. In addition, the
use of whole genome sequencing of the P1 and NP1 strains and
subsequent genome mining of NRPS gene clusters is a
promising future endeavour to identify additional secondary
metabolites not actively being produced under typical
cultivation conditions.
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